✦ LIBER ✦

Androgen receptor abnormalities in castration-recurrent prostate cancer

✍ Scribed by Nacusi, Lucas P; Tindall, Donald J

Book ID: 118150301
Publisher: Expert Reviews
Year: 2009
Tongue: English
Weight: 203 KB
Volume: 4
Category: Article
ISSN: 1744-6651
DOI: 10.1586/eem.09.34

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Androgen receptor (AR) aberrations in ca

Androgen receptor (AR) aberrations in castration-resistant prostate cancer

✍ Kati K. Waltering; Alfonso Urbanucci; Tapio Visakorpi 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 273 KB

Castration-resistant prostate cancer: Ta

Castration-resistant prostate cancer: Targeting androgen metabolic pathways in recurrent disease

✍ Elahe A. Mostaghel; Bruce Montgomery; Peter S. Nelson 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 549 KB

Androgen Receptor Directed Therapies in

Androgen Receptor Directed Therapies in Castration-Resistant Metastatic Prostate Cancer

✍ Kim, Won; Ryan, Charles J 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 197 KB

Targeting the androgen receptor signalli

Targeting the androgen receptor signalling axis in castration-resistant prostate cancer (CRPC)

✍ Che-Kai Tsao; Matthew D. Galsky; Alexander C. Small; Tiffany Yee; William K. Oh 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 314 KB

Targeted Therapies in Metastatic Castrat

Targeted Therapies in Metastatic Castration-Resistant Prostate Cancer: Beyond the Androgen Receptor

✍ Yohann Loriot; Amina Zoubeidi; Martin E. Gleave 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 694 KB

Androgen receptor action in hormone-depe

Androgen receptor action in hormone-dependent and recurrent prostate cancer

✍ Irina U. Agoulnik; Nancy L. Weigel 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB

## Abstract The importance of androgens and androgen receptors (AR) in primary prostate cancer is well established. Metastatic disease is usually treated with some form of androgen ablation, which is effective for a limited amount of time. The role of AR in prostate cancers that recur despite andro